He just might sell the stock to LPC at $25 a share and that would mean only 1 million shares of delusion. This is what I think will end up happening. He knows what we have and he is keeping big Pharma away with the notice that we have plenty of cash to go around and no need to raise one penny yet of big Pharma’s money. That will come when we need to partner for Alzheimer’s. That’s when one big Pharma will throw in $1 billion to us as an upfront payment for marketing rights. We will go it with alone for Parkinson’s disease dementia and Rhett syndrome. I also don’t believe we need a manufacturing partner as the supplies needed are not that great compared to say Alzheimer’s. Much easier to market and sell for these indications. Just my 2c.
News 
Market Data 
Discover 
